Grants in the United Kingdom
Explore grants for companies in the United Kingdom. This directory includes national and regional funding from UK innovation agencies, research funders and foundations, international programs open to applicants in the United Kingdom, and competitions any company can enter, with the deadline, award size and eligibility on every listing. Grants aimed at the United Kingdom come first.
Showing 1,705-1,728 of 2,158 grants
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33)
NIH · United States
Funds two years establishing that a psychosocial intervention hits its target, then three replicating it and linking it to clinical change.
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33)
NIH · United States
Funds early-stage testing of a novel-mechanism drug or a device for mental disorders, designed to show a dose-dependent effect on the target.
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33)
NIH · United States
Funds a feasibility phase then a testing phase for a novel-mechanism drug or a device for mental disorders, with milestones between them.
Effectiveness Trials to Test Mental Health System Interventions
NIH · United States
Funds a feasibility and infrastructure phase, then a well-powered trial, of an intervention aimed at how mental health services are organised and delivered.
Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions
NIH · United States
Funds a definitive trial of a mental health treatment or service in real community and practice settings, powered to settle the question.
Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions
NIH · United States
Funds a pilot effectiveness study of a mental health intervention — and requires it to test whether the intervention engages its presumed mechanism.
NEI Research Grant for Vision-Related Secondary Data Analysis
NIH · United States
Funds secondary analysis of vision-health data that already exists, and new statistical methods for getting more out of it.
Early-Stage Development of Informatics Technologies for Cancer Research and Management
NIH · United States
Funds early-stage development of new cancer-research software tools, from first prototype to their first real users.
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery
NIH · United States
Funds building animal and tissue models that behave enough like a real neurological disease to test drugs against.
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification
NIH · United States
Funds building the assays and running the screens that find drug candidates for neurological disease — the on-ramp to NIH's Blueprint network.
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies
NIH · United States
Funds the pharmacology and animal efficacy work that shows a neurological drug candidate is worth developing further.
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34)
NIH · United States
Funds the same preparatory work before a cancer prevention trial, as an ordinary grant rather than a cooperative agreement.
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34)
NIH · United States
Funds the preparatory study that answers the unknowns — accrual, endpoints, statistics, operations — before a cancer prevention trial is finalised.
BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain
NIH · United States
Funds computational tools, models and theories for understanding brain circuits, built to be shared broadly with the research community.
Basic Research in Cancer Health Disparities (R21)
NIH · United States
Funds early-stage mechanistic work on the biological and genetic causes of cancer health disparities, on a shorter and smaller footing.
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01)
NIH · United States
Funds new screening tests or treatments for serious newborn conditions — including ones not yet on any screening panel.
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21)
NIH · United States
Funds the exploratory version of the same work on screening tests and treatments for serious newborn conditions.
DEVCOM ARMY RESEARCH LABORATORY BROAD AGENCY ANNOUNCEMENT FOR FOUNDATIONAL RESEARCH
AMC · United States
Funds basic and applied research across the Army Research Laboratory's whole science mission, with live topics posted on the lab's own separate site.
Accelerating the Pace of Substance Use Research Using Existing Data (R01)
NIH · United States
Funds new analysis of existing social, behavioral, administrative and neuroimaging data on drug use, prevention, and related health services.
Accelerating the Pace of Substance Use Research Using Existing Data (R21)
NIH · United States
Funds the exploratory R21 version of new analysis on existing social, behavioral, administrative and neuroimaging drug-use data.
DEVCOM ANALYSIS CENTER BROAD AGENCY ANNOUNCEMENT FOR APPLIED RESEARCH
AMC · United States
Funds applied research and prototype-stage work for the Army unit that turns data into modernization and readiness decisions.
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment
NIH · United States
Funds academic-industry partnerships that turn a lab discovery into a working diagnostic or treatment tool, without a clinical trial attached.
Basic Research in Cancer Health Disparities (R01)
NIH · United States
Funds basic mechanistic research into the biological and genetic causes of cancer health disparities — and into building the tools that research needs.
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies
NIH · United States
Funds mechanistic work on the lasting harms cancer therapy causes, and on turning that understanding into ways to prevent them.